Key Market Indicators
Latvian hormones sales are expected to reach $8.96 million by 2026. In 2021, the market was valued at $8.25 million, growing at an average of 1.7% year-on-year. Since 2006, Latvian hormones sales have grown by 4.3% year-on-year, ranking 25th in 2021. Slovenia overtook Latvia at $8.25 million. Germany, the United Kingdom, and Italy were the second, third, and fourth largest markets, respectively.
